Clinical Trial Update: Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease [NA]

View source ↗

Summary

A clinical trial update on the evaluation of NVP-NK4146 in Alzheimer disease-related mild cognitive impairment, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NVP-NK4146 (NVP-NK4146)

Snippet

Sponsor: NVP Healthcare | Conditions: Alzheimer Disease | NA | Status: NOT_YET_RECRUITING